Neuland Laboratories

11,915.05
+5.80
(0.05%)
Market Cap
15,286.88 Cr
EPS
233.89
PE Ratio
63.66
Dividend Yield
0.12 %
Industry
Healthcare
52 Week High
18,100.00
52 Week Low
5,540.10
PB Ratio
10.96
Debt to Equity
0.10
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+100.00 %
+100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,764.75 4,23,422.64 36.32 49,887.20 12.06 9,648 13.77 61.58
5,840.65 1,55,050.91 75.90 8,184.00 0.89 1,600 64.53 55.23
1,511.20 1,22,046.63 24.67 26,520.70 14.17 4,155 47.38 60.28
3,245.05 1,09,827.24 59.25 10,785.70 11.59 1,656 13.54 61.68
2,398.05 98,935.61 47.95 10,615.60 19.57 1,942 -16.38 56.07
1,177.90 98,285.26 18.80 28,905.40 12.36 5,578 1.69 51.86
2,068.75 94,375.87 33.76 20,141.50 19.94 1,936 38.82 54.50
907.35 91,300.64 20.56 19,831.50 13.82 3,831 29.92 48.54
1,194.95 69,402.89 19.93 29,559.20 17.55 3,169 -10.04 61.05
31,101.85 66,089.26 49.48 6,097.20 10.80 1,201 16.01 61.04
Growth Rate
Revenue Growth
30.83 %
Net Income Growth
83.55 %
Cash Flow Change
10.10 %
ROE
42.19 %
ROCE
47.41 %
EBITDA Margin (Avg.)
28.96 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
155
169
172
174
182
187
205
193
206
242
246
259
203
258
238
257
222
294
270
415
365
421
395
390
465
315
458
Expenses
145
154
156
154
162
161
176
162
172
201
199
219
175
215
204
217
193
224
215
287
266
280
272
278
316
249
311
EBITDA
10
15
16
20
19
26
29
32
35
42
47
40
28
43
34
40
29
70
55
128
99
141
123
112
149
67
146
Operating Profit %
6 %
9 %
9 %
11 %
10 %
13 %
14 %
16 %
16 %
17 %
19 %
10 %
13 %
17 %
14 %
15 %
13 %
24 %
20 %
29 %
27 %
33 %
31 %
28 %
28 %
20 %
22 %
Depreciation
6
6
7
7
8
8
8
8
9
9
10
11
12
12
13
12
13
13
13
14
14
15
15
17
16
16
16
Interest
4
4
3
5
4
5
6
7
5
4
4
5
4
4
3
3
3
3
3
4
2
4
4
4
3
1
2
Profit Before Tax
1
5
6
8
8
12
16
17
20
29
32
24
12
28
18
24
14
53
39
110
83
122
105
92
130
49
128
Tax
0
1
1
2
2
4
5
27
5
7
5
7
3
7
5
3
4
15
8
26
21
32
23
25
32
17
26
Net Profit
1
5
5
7
6
9
11
-9
15
21
27
17
9
20
13
22
10
39
31
85
62
89
81
68
98
33
102
EPS in ₹
0.44
3.55
3.66
5.17
4.45
6.77
8.66
-7.25
11.82
16.71
20.84
13.48
6.81
15.88
10.08
16.97
7.77
29.97
23.81
65.90
48.23
69.56
63.44
52.66
76.28
25.60
79.18

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
512
524
886
1,071
1,130
1,231
1,325
1,384
1,580
1,833
Fixed Assets
123
139
466
475
542
653
716
767
758
824
Current Assets
316
314
375
447
454
515
550
581
761
921
Capital Work in Progress
42
41
20
126
105
24
17
21
41
46
Investments
0
0
8
8
8
8
7
4
1
1
Other Assets
347
345
393
463
477
547
585
592
781
962
Total Liabilities
512
524
886
1,071
1,130
1,231
1,325
1,384
1,580
1,833
Current Liabilities
295
268
286
367
327
358
369
363
439
428
Non Current Liabilities
55
69
54
146
104
163
170
180
147
122
Total Equity
162
187
546
558
699
710
787
841
994
1,283
Reserve & Surplus
152
178
537
549
686
697
774
828
981
1,270
Share Capital
9
9
9
9
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
1
-4
-0
5
3
-9
3
40
42
Investing Activities
-14
-20
-42
-116
-77
-49
-85
-95
-61
-150
Operating Activities
13
45
39
11
70
57
189
60
237
261
Financing Activities
1
-24
-0
105
12
-6
-114
38
-136
-69

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.14 %
36.14 %
36.03 %
35.97 %
32.80 %
32.74 %
32.72 %
32.64 %
32.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
21.57 %
22.69 %
24.44 %
25.72 %
26.46 %
23.86 %
DIIs
0.87 %
0.04 %
0.80 %
0.80 %
0.80 %
0.80 %
6.58 %
6.55 %
7.10 %
6.76 %
6.99 %
6.03 %
6.54 %
6.39 %
6.38 %
9.08 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.44 %
0.46 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
Public / Retail
34.06 %
36.62 %
33.19 %
32.84 %
32.43 %
33.25 %
31.03 %
30.09 %
29.86 %
29.01 %
27.86 %
29.51 %
27.97 %
27.05 %
26.50 %
26.05 %
Others
28.85 %
27.12 %
29.80 %
30.15 %
30.56 %
29.74 %
25.73 %
26.76 %
26.51 %
27.80 %
7.21 %
8.57 %
7.91 %
7.71 %
7.61 %
7.93 %
No of Share Holders
0
22,412
34,978
34,332
32,426
32,257
31,976
30,600
26,948
25,223
26,824
27,723
28,616
29,077
34,567
39,315

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 2 5 5 10 14 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.1 0.49 0.28 0.16 0.12 0.00

Corporate Action

Announcements

Closure of Trading Window
3 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 days ago
Announcement under Regulation 30 (LODR)-Credit Rating
Mar 10, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Mar 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Mar 03, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Mar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
Feb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
Feb 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Feb 25, 2025
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 11, 2025
Integrated Filing (Financial)
Feb 10, 2025
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 10, 2025
Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024
Feb 10, 2025
Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024
Feb 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 03, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Jan 31, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024
Jan 23, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 21, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jan 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 03, 2025
Update On Final Transfer Of Part Of Nanakramguda Property
Dec 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 02, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Nov 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 28, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Nov 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 20, 2024
Update On Further Transfer Of Part Of Nanakramguda Property
Nov 12, 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 12, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 07, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 07, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 06, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 06, 2024
Announcement under Regulation 30 (LODR)-Investor Presentation
Nov 06, 2024
Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024
Nov 06, 2024
Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024
Nov 06, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Oct 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 24, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 18, 2024
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024
Oct 17, 2024
Clarification On Recent News In The Media / Social Media
Oct 16, 2024

Technical Indicators

RSI(14)
Neutral
50.88
ATR(14)
Less Volatile
658.73
STOCH(9,6)
Neutral
57.54
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
176.15
ADX(14)
Weak Trend
13.55
UO(9)
Bearish
52.05
ROC(12)
Uptrend And Accelerating
0.93
WillR(14)
Neutral
-36.40